1-204950569-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BS1
The NM_001005388.3(NFASC):āc.104A>Gā(p.Asn35Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,612,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001005388.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFASC | NM_001005388.3 | c.104A>G | p.Asn35Ser | missense_variant | 4/30 | ENST00000339876.11 | NP_001005388.2 | |
NFASC | NM_001160331.2 | c.92-1442A>G | intron_variant | ENST00000539706.6 | NP_001153803.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFASC | ENST00000339876.11 | c.104A>G | p.Asn35Ser | missense_variant | 4/30 | 5 | NM_001005388.3 | ENSP00000344786.6 | ||
NFASC | ENST00000539706.6 | c.92-1442A>G | intron_variant | 5 | NM_001160331.2 | ENSP00000438614.2 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000527 AC: 13AN: 246756Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133964
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1460560Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726398
GnomAD4 genome AF: 0.000223 AC: 34AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74456
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at